X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3228) 3228
Publication (682) 682
Book / eBook (257) 257
Book Review (61) 61
Book Chapter (8) 8
Conference Proceeding (8) 8
Data Set (4) 4
Dissertation (4) 4
Magazine Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2803) 2803
urologic and male genital diseases (1957) 1957
index medicus (1948) 1948
male (1934) 1934
oncology (1309) 1309
female (1115) 1115
cancer (1001) 1001
middle aged (992) 992
aged (963) 963
prostate cancer (695) 695
urologic neoplasms - drug therapy (695) 695
cell line, tumor (665) 665
animals (607) 607
female genital diseases and pregnancy complications (593) 593
adult (558) 558
chemotherapy (526) 526
metastasis (468) 468
care and treatment (466) 466
urology & nephrology (465) 465
treatment outcome (447) 447
neoplasms (437) 437
urology (436) 436
research (411) 411
tumors (408) 408
article (405) 405
aged, 80 and over (402) 402
antineoplastic combined chemotherapy protocols - therapeutic use (401) 401
antineoplastic agents - therapeutic use (400) 400
mice (374) 374
medicine (370) 370
expression (369) 369
urologic neoplasms - pathology (352) 352
research article (342) 342
prostatic neoplasms - pathology (341) 341
apoptosis (338) 338
therapy (332) 332
prognosis (330) 330
carcinoma, transitional cell - drug therapy (319) 319
prostatic neoplasms - drug therapy (304) 304
carcinoma (296) 296
kidney neoplasms - drug therapy (286) 286
survival (278) 278
prostatic neoplasms - metabolism (275) 275
health aspects (270) 270
renal cell carcinoma (266) 266
cancer therapies (263) 263
kidney neoplasms - pathology (259) 259
carcinoma, renal cell - drug therapy (253) 253
urologic diseases (253) 253
drug therapy (252) 252
gene expression (250) 250
multidisciplinary sciences (247) 247
proteins (247) 247
prostate (246) 246
cell biology (245) 245
neoplasms. tumors. oncology. including cancer and carcinogens (240) 240
diagnosis (236) 236
retrospective studies (236) 236
risk factors (236) 236
neoplasm metastasis (231) 231
analysis (224) 224
cisplatin (224) 224
bladder cancer (223) 223
cell proliferation - drug effects (220) 220
urogenital system (219) 219
carcinoma, renal cell - pathology (215) 215
cisplatin - administration & dosage (215) 215
development and progression (213) 213
science (210) 210
androgens (209) 209
bladder-cancer (206) 206
antineoplastic agents - pharmacology (205) 205
review (204) 204
genetic aspects (201) 201
surgery (201) 201
prostatic neoplasms - genetics (200) 200
sunitinib (198) 198
patients (197) 197
gene expression regulation, neoplastic (191) 191
kinases (190) 190
progression (187) 187
receptors, androgen - metabolism (186) 186
carcinoma, renal cell (182) 182
disease-free survival (182) 182
neoplasm staging (182) 182
studies (182) 182
sorafenib (180) 180
urinary bladder neoplasms - drug therapy (178) 178
mice, nude (177) 177
signal transduction (176) 176
disease progression (170) 170
xenograft model antitumor assays (168) 168
diseases (167) 167
medical prognosis (165) 165
urothelial carcinoma (165) 165
apoptosis - drug effects (162) 162
metastases (162) 162
antineoplastic combined chemotherapy protocols - adverse effects (161) 161
growth (160) 160
urologic neoplasms - mortality (160) 160
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (214) 214
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Scarborough Hospital - General (7) 7
Holland Bloorview Kids Rehabilitation - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Online Resources - Online (4) 4
Credit Valley Hospital - Stacks (3) 3
Humber River Regional Hospital - Church Stacks (3) 3
Scarborough Hospital - Birchmount (3) 3
St. Michael's Hospital - Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Providence Healthcare - Reference (2) 2
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Not Returned (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Reserve desk (1) 1
St Josephs Health Centre - Stacks (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT Schools - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3250) 3250
Japanese (98) 98
German (64) 64
French (31) 31
Italian (17) 17
Spanish (12) 12
Russian (9) 9
Turkish (5) 5
Chinese (4) 4
Portuguese (4) 4
Polish (3) 3
Bulgarian (2) 2
Dutch (2) 2
Hungarian (2) 2
Arabic (1) 1
Danish (1) 1
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 270 - 273
Journal Article
Nature, ISSN 0028-0836, 02/2018, Volume 554, Issue 7693, pp. 544 - 548
Therapeutic antibodies that block the programmed death-1 (PD-1)-programmed death-ligand 1 (PD-L1) pathway can induce robust and durable responses in patients... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | BLADDER-CANCER | THERAPY | LANDSCAPE | SUBTYPES | UROTHELIAL CARCINOMA | MULTIDISCIPLINARY SCIENCES | GENES | ADAPTIVE IMMUNE RESISTANCE | MPDL3280A | CD8-Positive T-Lymphocytes - cytology | Humans | Antibodies, Monoclonal - therapeutic use | Urothelium - pathology | Urologic Neoplasms - pathology | Neoplasm Metastasis | Urologic Neoplasms - drug therapy | Urologic Neoplasms - genetics | Immunotherapy | Antibodies - immunology | Antigens, Neoplasm - metabolism | Transforming Growth Factor beta - antagonists & inhibitors | Antigens, Neoplasm - analysis | Disease Models, Animal | Fibroblasts - metabolism | Antibodies - therapeutic use | Antigens, Neoplasm - immunology | Antibodies, Monoclonal - pharmacology | Treatment Outcome | B7-H1 Antigen - immunology | Urologic Neoplasms - immunology | Antibodies - pharmacology | Tumor Microenvironment - immunology | Collagen - metabolism | Phenotype | Animals | B7-H1 Antigen - antagonists & inhibitors | Signal Transduction - drug effects | Cell Cycle Checkpoints - drug effects | CD8-Positive T-Lymphocytes - drug effects | Urothelium - immunology | Mice | Mutation | CD8-Positive T-Lymphocytes - immunology | Urothelium - drug effects | Transforming Growth Factor beta - metabolism | Cohort Studies | Drug Resistance, Neoplasm - drug effects | PD-1 protein | CD8 antigen | Transforming growth factor-a | Antibodies | Parenchyma | Lymphocytes T | Metastasis | Immunity | Metastases | Genotype & phenotype | Signal transduction | Lymphocytes | Cell cycle | Fibroblasts | Growth factors | Urothelial cancer | Phenotypes | Cytokines | Melanoma | Blocking | Gene expression | Patients | Generalized linear models | Signaling | Stromal cells | Medical prognosis | Collagen | PD-L1 protein | Ligands | Determinants | Infiltration | Cancer | Tumors | Apoptosis | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 312 - 322
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 68, Issue 5, pp. 837 - 847
Journal Article
European Urology, ISSN 0302-2838, 2014, Volume 66, Issue 4, pp. 704 - 710
Journal Article
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2011, Volume 22, Issue 5, pp. 611 - 621
Journal Article
Cancer, ISSN 0008-543X, 06/2014, Volume 120, Issue 12, pp. 1794 - 1799
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2018, Volume 379, Issue 5, pp. 417 - 427
Journal Article
Cancer Discovery, ISSN 2159-8274, 11/2013, Volume 3, Issue 11, pp. 1245 - 1253
Journal Article
Oncogene, ISSN 0950-9232, 05/2016, Volume 35, Issue 21, pp. 2687 - 2697
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell carcinoma (RCC). The purpose of this study was to understand the... 
ACTIVATION | METASTASIS | ANGIOGENESIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CELL BIOLOGY | RECEPTOR TYROSINE KINASES | CABOZANTINIB XL184 | ONCOLOGY | C-MET | GROWTH | GENETICS & HEREDITY | EXPRESSION | PROGRESSION | Proto-Oncogene Proteins c-met - metabolism | Humans | Drug Resistance, Neoplasm | Molecular Targeted Therapy | Sunitinib | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Carcinoma, Renal Cell - enzymology | Indoles - pharmacology | Carcinoma, Renal Cell - drug therapy | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Signal Transduction | Carcinoma, Renal Cell - pathology | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Proto-Oncogene Proteins - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Proto-Oncogene Proteins c-met - genetics | Xenograft Model Antitumor Assays | Pyrroles - pharmacology | Animals | Receptor Protein-Tyrosine Kinases - genetics | Mice, Nude | Kidney Neoplasms - enzymology | Kidney Neoplasms - pathology | Cell Proliferation - drug effects | Mice | Kidney Neoplasms - drug therapy | Molecular targeted therapy | Genetic aspects | Carcinoma, Renal cell | Drug therapy | Drug resistance | Properties | Phosphotransferases | Methods | Cancer therapies | Kidney cancer | Metastasis | Cabozantinib | Renal Cell Carcinoma | AXL | MET
Journal Article